1,219 results on '"Marquez, Victor E."'
Search Results
52. Supplementary Figure 1 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
53. Supplementary Methods from Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
54. Supplementary Figure 4 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
55. Supplementary Table 2 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
56. Supplementary Table 3 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
57. Supplementary Table 4 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
58. Supplementary Figure 5 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
59. Supplementary Table 3 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
60. Supplementary Table 4 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
61. Supplementary Table 1 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
62. Data from Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
63. Supplementary Figure 1 from Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
64. Data from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
65. Data from EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
66. Supplementary Figure Legend from Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
67. Data from Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
68. Supplementary Tables 1-3 from EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
69. Supplementary Data 2 from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
70. Supplementary Tables 1-6 from Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
71. Supplementary Data 1 from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
72. Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP
73. MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)
74. Enhancer of Zeste Homolog 2 Silences MicroRNA-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin
75. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors
76. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
77. Polycomb genes and cancer: Time for clinical application?
78. Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation
79. The effect on quadruplex stability of North-nucleoside derivatives in the loops of the thrombin-binding aptamer
80. Molecular Basis for Failure of “Atypical” C1 Domain of Vav1 to Bind Diacylglycerol/Phorbol Ester
81. Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells
82. Maternal diet and aging alter the epigenetic control of a promoter–enhancer interaction at the Hnf4a gene in rat pancreatic islets
83. Structural Basis of Actin Recognition and Arginine ADP-Ribosylation by Clostridium perfringens ι-Toxin
84. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
85. Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
86. Understanding the effects of carbocyclic sugars constrained to north and south conformations on RNA nanodesign
87. Epigenetic regulation of CIITA expression in human T-cells
88. Conformational Studies and Anti-HIV Activity of Mono- and Difluorodideoxy Nucleosides
89. TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration
90. Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli
91. Using conformationally locked nucleosides to calibrate the anomeric effect: implications for glycosyl bond stability
92. Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors
93. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
94. Ceramides: Branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency
95. A greener enantioselective synthesis of the antiviral agent North-methanocarbathymidine (N-MCT) from 2-deoxy- d-ribose
96. DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site
97. The Ups and Downs in Drug Design
98. Characterization of the Interaction of Phorbol Esters with the C1 Domain of MRCK (Myotonic Dystrophy Kinase-related Cdc42 Binding Kinase) α/β
99. 2′-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1
100. Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.